Study to Evaluate the Bioequivalence of a Test Tablet Formulation of Topiramate (2 x 25 mg), Compared to an Equivalent Dose of a Commercially Available Reference Drug Product (Topamax®, Ortho-McNeil Neurologics, Inc.) in Fasted, Healthy, Adult Subjects

This study has been completed.

Sponsor:

Information provided by:

Torrent Pharmaceuticals Limited

ClinicalTrials.gov Identifier:

NCT00939692

First received: July 13, 2009

Last updated: July 15, 2009

Last verified: July 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given